TUKYSA
NDC 51144-001, tucatinib, tablet, from SEAGEN INC..
- Product NDC
- 51144-001
- Status
- Listed
- Labeler
- SEAGEN INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA213411
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51144-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TUCATINIB50 mg/1
Pharmacologic classes
Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Kinase Inhibitor [EPC]; P-Glycoprotein Inhibitors [MoA]; Tyrosine Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51144-001-60 | 51144000160 | 60 TABLET in 1 BOTTLE (51144-001-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f27eb1b9-b7fc-424e-988f-84dd7bb195a3
Use it
Look up 51144-001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51144-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51144-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.